# Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

> **NCT04133012** · NA · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 20 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **OTHER:** Samplings

## Key facts

- **NCT ID:** NCT04133012
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-10
- **Primary completion:** 2023-06-09
- **Final completion:** 2023-06-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04133012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04133012, "Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04133012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*